Prelude Capital Management’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Prelude Capital Management’s Portfolio PEPLW Stock Details PEPLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-77,770	Closed	-$7.4K	–	1423
2023 Q1	$7.4K	Hold	77,770	–	–	﹤0.01%	1076
2022 Q4	$1.19K	Hold	77,770	–	–	﹤0.01%	1258
2022 Q3	$6K	Hold	77,770	–	–	﹤0.01%	1351
2022 Q2	$20K	Hold	77,770	–	–	﹤0.01%	1536
2022 Q1	$32K	Buy	+77,770	New	+$33.5K	﹤0.01%	1517

Other funds holding PEPLW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Prelude Capital Management's PEPLW Position: Q2 2023 in Review

Prelude Capital Management sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q2 2023, closing a stake of 77,770 shares — an estimated $7.4K sold.

Prelude Capital Management first reported a position in PEPLW in Q1 2022 and held it in 5 quarters. The position peaked at $32K in Q1 2022. 16 funds tracked by Wall St. Rank hold PEPLW as of Q2 2023.

Prelude Capital Management reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q2 2023 after selling out during the quarter.
Prelude Capital Management sold 77,770 PepperLime Health Acquisition Corporation Warrrant shares in Q2 2023, an estimated $7.4K.
Prelude Capital Management first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q1 2022 and held it in 5 quarters.
Prelude Capital Management's PepperLime Health Acquisition Corporation Warrrant position peaked at $32K in Q1 2022.
16 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q2 2023.

Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.